Intravenous immunoglobulin in isoimmune haemolytic disease of newborn: An updated systematic review and meta-analysis

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 99, Issue 4, 2014, Pages

  Louis, Deepak ^a   More, Kiran ^b   Oberoi, Sapna ^b   Shah, Prakesh S ^a,c,d  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

^c MOUNT SINAI HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; IMMUNOGLOBULIN; PLACEBO;

ATTRIBUTABLE RISK; BILIRUBIN BLOOD LEVEL; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD TRANSFUSION; COCHRANE LIBRARY; DATA BASE; DRUG EFFICACY; DRUG SAFETY; EMBASE; EXCHANGE BLOOD TRANSFUSION; HEMOLYTIC ANEMIA; HUMAN; MEDLINE; META ANALYSIS; OUTCOME ASSESSMENT; PHOTOTHERAPY; PREMATURITY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REVIEW; RHESUS INCOMPATIBILITY; RHESUS ISOIMMUNIZATION; RISK BENEFIT ANALYSIS; SENSITIVITY ANALYSIS; SYSTEMATIC REVIEW;

BIAS (EPIDEMIOLOGY); ERYTHROBLASTOSIS, FETAL; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT, NEWBORN; INFANT, PREMATURE; INFANT, PREMATURE, DISEASES; RH ISOIMMUNIZATION; TREATMENT OUTCOME;

EID: 84902380908     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/archdischild-2013-304878     Document Type: Review

References (39)

1. Urbaniak SJ. ADCC (K-cell)lysis of human erythrocytes sensitized with rhesus alloantibodies. I. Investigation of in vitro culture variables. Br J Haematol 1979;42:303 -14.
2. Smits-Wintjens VE, Walther FJ, Lopriore E. Rhesus haemolytic disease of the newborn: Postnatal management, associated morbidity and long-term outcome. Semin Fetal Neonatal Med 2008;13:265-71.
3. Keenan WJ, Novak KK, Sutherland JM, et al. Morbidity and mortality associated with exchange transfusion. Pediatrics 1985;75:417-21. (Pubitemid 15172372)
4. Patra K, Storfer-Isser A, Siner B, et al. Adverse events associated with neonatal exchange transfusion in the 1990s. J Pediatr 2004;144:626-31. (Pubitemid 38594764)
5. Steiner LA, Bizzarro MJ, Ehrenkranz RA, et al. A decline in the frequency of neonatal exchange transfusions and its effect on exchange-related morbidity and mortality. Pediatrics 2007;120:27-32. (Pubitemid 47036237)
6. Maisels M, Baltz RD, Bhutanu VK, et al. Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics 2004;114:297-316.
7. Ballow M. The IgG molecule as a biological immune response modifier: mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders. J Allergy Clin Immunol 2011;127:315-23; quiz 24-5.
8. Rubo J, Albrecht K, Lasch P, et al. High-dose intravenous immune globulin therapy for hyperbilirubinemia caused by Rh hemolytic disease. J Pediatr 1992;121:93-7.
9. Alpay F, Sarici SU, Okutan V, et al. High-dose intravenous immunoglobulin therapy in neonatal immune haemolytic jaundice. Acta Paediatr 1999;88:216-19. (Pubitemid 29124328)
10. Dagoglu T, Ovali F, Samanci N, et al. High-dose intravenous immunoglobulin therapy for rhesus haemolytic disease. J Int Med Res 1995;23:264-71.
11. Nasseri F, Mamouri GA, Babaei H. Intravenous immunoglobulin in ABO and Rh hemolytic diseases of newborn. Saudi Med J 2006;27:1827-30. (Pubitemid 351863312)
12. Voto LS, Sexer H, Ferreiro G, et al. Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic disease. J Perinat Med 1995;23:443-51. (Pubitemid 26052734)
13. Miqdad AM, Abdelbasit OB, Shaheed MM, et al. Intravenous immunoglobulin G (IVIG) therapy for significant hyperbilirubinemia in ABO hemolytic disease of the newborn. J Matern Fetal Neonatal Med 2004;16:163-6. (Pubitemid 40006903)
14. Fischer GW. Therapeutic uses of intravenous gammaglobulin for pediatric infections. Pediatr Clin North Am 1988;35:517-33.
15. Figueras-Aloy J, Rodriguez-Miguelez JM, Iriondo-Sanz M, et al. Intravenous immunoglobulin and necrotizing enterocolitis in newborns with hemolytic disease. Pediatrics 2010;125:139-44.
16. Krishnan L, Pathare A. Necrotizing enterocolitis in a term neonate following intravenous immunoglobulin therapy. Indian J Pediatr 2011;78:743-4.
17. Merlob P, Mor N, Reisner SH. Epispadias with complete prepuce and phimosis in a neonate. Clin Pediatr (Phila) 1987;26:43-5. (Pubitemid 17222152)
18. Navarro M, Negre S, Matoses ML, et al. Necrotizing enterocolitis following the use of intravenous immunoglobulin for haemolytic disease of the newborn. Acta Paediatr 2009;98:1214-17.
19. Corvaglia L, Legnani E, Galletti S, et al. Intravenous immunoglobulin to treat neonatal alloimmune haemolytic disease. J Matern Fetal Neonatal Med 2012;25:2782-5.
20. Copelan EA, Strohm PL, Kennedy MS, et al. Hemolysis following intravenous immune globulin therapy. Transfusion 1986;26:410-12. (Pubitemid 17168374)
21. Alcock GS, Liley H. Immunoglobulin infusion for isoimmune haemolytic jaundice in neonates. Cochrane Database Syst Rev 2002;3:CD003313.
22. Gottstein R, Cooke RW. Systematic review of intravenous immunoglobulin in haemolytic disease of the newborn. Arch Dis Child Fetal Neonatal Ed 2003;88:F6-10.
23. Li ZH, Wang J, Chen C. [Meta analysis of the effect of immunoglobulin infusion on neonatal isoimmune hemolytic disease caused by blood group incompatibility]. Zhonghua Er Ke Za Zhi 2010;48:656-60.
24. Smits-Wintjens VE, Walther FJ, Rath ME, et al. Intravenous immunoglobulin in neonates with rhesus hemolytic disease: a randomized controlled trial. Pediatrics 2011;127:680-6.
25. Santos MC, Sa C, Gomes SC Jr, et al. The efficacy of the use of intravenous human immunoglobulin in Brazilian newborns with rhesus hemolytic disease: a randomized double-blind trial. Transfusion 2013;53:777-82.
26. Liberati A, Altman DG, Tetzlaff J, et al. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ 2009;339:b2700.
27. Higgins JP, Altman DG, Gotzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ 2011;343:d5928.
28. Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011;343:d4002.
29. Tanyer G, Siklar Z, Dallar Y, et al. Multiple dose IVIG treatment in neonatal immune hemolytic jaundice. J Trop Pediatr 2001;47:50-3. (Pubitemid 32170937)
30. Atici A, Satar M, Gogebakan M. Abo Veya Rh Uyusmazliginin Neden Oldugu Neonatal Hiperbilirubinemide Intravenoz Immunglobulin Tedavisi. Cocuk Sagligi ve Hastaliklari Dergisi 1996;39:623-30. (Pubitemid 26365019)
31. Rubo J, Wahn V, Hohendahl J, et al. Kooperative Studie Zum Einfluss Einer Hochdosierten Immunglobulintherapie Auf Die Hyperbilirubinamie Bei Rhesusinkompatibilitat. Monatsschrift fur Kinderheilkunde 1996;144:516-19. (Pubitemid 26167623)
32. Hematyar M, Zareian M. The effects of intravenous immunoglobulin in hemolytic jaundice of the newborn due to ABO and RH ioimmunization. Acta Paediatrica, International Journal of Paediatrics 2011;100:71.
33. Pishva N, Madani A, Homayoon K. Prophylactic intravenous immunoglobulin in neonatal immune hemolytic jaundice. Irn J Med Sci 2000;25:129-33. (Pubitemid 32428447)
34. Elalfy MS, Elbarbary NS, Abaza HW. Early intravenous immunoglobin (two-dose regimen) in the management of severe Rh hemolytic disease of newborn - a prospective randomized controlled trial. Eur J Pediatr 2011;170:461-7.
35. Garcia MG, Cordero G, Mucino P, et al. Intravenous immunoglobulin (IVIG) administration as a treatment for Rh hemolytic jaundice in Mexico City. Pediatr Res 2004;55:65.
36. Huang WM, Chen HW, Li N, et al. [Clinical study of early interventions for ABO hemolytic disease of the newborn]. Nan Fang Yi Ke Da Xue Xue Bao 2006;26:1350-1, 5.
37. Grundbacher FJ. The etiology of ABO hemolytic disease of the newborn. Transfusion 1980;20:563-8. (Pubitemid 11207619)
38. Romano EL, Mollison PL, Linares J. Number of B sites generated on group O red cells from adults and newborn infants. Vox Sang 1978;34:14-17. (Pubitemid 8228569)
39. Brouwers HA, Overbeeke MA, Huiskes E, et al. Complement is not activated in ABO-haemolytic disease of the newborn. Br J Haematol 1988;68:363-6.